Advertisement

Topics

"CoreChoice MINES Associates Introduce First Opioid Substance Disorders" Drugs and Medication Database

07:24 EDT 20th March 2019 | BioPortfolio

Here are the most relevant "CoreChoice MINES Associates Introduce First Opioid Substance Disorders" Drugs and Medications that we have found in our database.

More Information about "CoreChoice MINES Associates Introduce First Opioid Substance Disorders" on BioPortfolio

We have published hundreds of CoreChoice MINES Associates Introduce First Opioid Substance Disorders news stories on BioPortfolio along with dozens of CoreChoice MINES Associates Introduce First Opioid Substance Disorders Clinical Trials and PubMed Articles about CoreChoice MINES Associates Introduce First Opioid Substance Disorders for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CoreChoice MINES Associates Introduce First Opioid Substance Disorders Companies in our database. You can also find out about relevant CoreChoice MINES Associates Introduce First Opioid Substance Disorders Drugs and Medications on this site too.

Showing "CoreChoice MINES Associates Introduce First Opioid Substance Disorders" Drugs and Medications 1–25 of 325

Probably Relevant

Quflora pediatric [carwin pharmaceutical associates, llc]

Quflora™ Pediatric Chewable Tablets

Quflora pediatric drops [carwin pharmaceutical associates, llc]

Quflora 0.25 mg/mL F* Pediatric Fluoride Drops

Quflora pediatric drops [carwin pharmaceutical associates, llc]

Quatrefolic 0.5 mg/mL F* Pediatric Fluoride Drops

Quflora fe pediatric drops [carwin pharmaceutical associates, llc]

Quflora FE Pediatric Liquid Drops

Ibuprofen [pharmaceutical associates, inc.]

Ibuprofen Oral Suspension USP 100 mg/5 mL

Ryclora [carwin pharmaceutical associates, llc]

RYCLORA™ (dexchlorpheniramine maleate) Oral Solution, USP

Possibly Relevant

Oxygen [hawaii home infusion associates, ltd.]

Oxygen, USP

Tristart dha [carwin pharmaceutical associates, llc]

TriStart DHA PRENATAL SUPPLEMENT

Sodium citrate and citric acid [pharmaceutical associates, inc.]

Sodium Citrate and Citric Acid Oral Solution USP

Nystatin [pharmaceutical associates, inc.]

Nystatin Oral Suspension USP

Buprenorphine [lake erie medical dba quality care products llc]

These highlights do not include all the information needed to use BUPRENORPHINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for BUPRENORPHINE TRANSDERMAL SYSTEM. Buprenorphine Transdermal System CIII Initial U.S. Approval:

Tricitrates [pharmaceutical associates, inc.]

Tricitrates SF Oral Solution

Buprenorphine [teva pharmaceuticals usa, inc.]

These highlights do not include all the information needed to use BUPRENORPHINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for BUPRENORPHINE TRANSDERMAL SYSTEM. BUPRENORPHINE Transdermal System for transdermal administrati

Buprenorphine [lake erie medical dba quality care products llc]

These highlights do not include all the information needed to use BUPRENORPHINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for BUPRENORPHINE TRANSDERMAL SYSTEM. BUPRENORPHINE Transdermal System for transdermal administrati

Lactulose [pharmaceutical associates, inc,]

Lactulose Solution USP 10 g/15 mL

Buprenorphine [rhodes pharmaceuticals l.p.]

These highlights do not include all the information needed to use BUPRENORPHINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for BUPRENORPHINE TRANSDERMAL SYSTEM. Buprenorphine Transdermal System CIII Initial U.S. Approval:

Oxygen [home equipment associates, inc.]

oxygen

Hydrocodone bitartrate and homatropine methylbromide [pharmaceutical associates, inc.]

HYDROCODONE BITARTRATE and HOMATROPINE METHYLBROMIDE SYRUP CII

Buprenorphine [teva pharmaceuticals usa, inc.]

These highlights do not include all the information needed to use BUPRENORPHINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for BUPRENORPHINE TRANSDERMAL SYSTEM. BUPRENORPHINE transdermal system CIII Initial U.S. Approval:

Nystatin [pharmaceutical associates, inc.]

Nystatin Oral Suspension USP [100,000 units per mL]

Oxygen [apple homecare associates, inc.]

NA

Glycate [carwin pharmaceutical associates, llc]

Glycate (Glycopyrrolate Tablets, USP) 1.5 mg

Diphenhydramine hydrochloride [pharmaceutical associates, inc.]

Diphenhydramine Hydrochloride Oral Solution USP

Potassium citrate and citric acid [pharmaceutical associates, inc.]

Potassium Citrate and Citric Acid Oral Solution USP

Ranitidine [pharmaceutical associates, inc.]

Ranitidine Syrup (Ranitidine Oral Solution USP)



Advertisement
Quick Search
Advertisement
Advertisement